Overview
Sopartec operates within the Louvain Technology Transfer Office (LTTO) to commercialize research results from UCLouvain, Cliniques universitaires St-Luc, CHU UCL Namur, and the Institut de Duve through spin-off creation and licensing. The company works in partnership with Vives investment funds, which are multisectoral funds investing in UCLouvain spin-offs and technology startups in Belgium and neighboring countries. Sopartec has created 95 spin-offs with 77 currently active and 105 active patent families.
In the news
- Intercept Bio: Towards a nasal spray to prevent viral respiratory infections Intercept Bio is a recently created spin-off founded jointly by UCLouvain and UNamur. Its ambition is to develop an innovative nasal spray designed to intercept respiratory viruses at one of the earliest stages of infection, when they attach to human cells. The project emerged from a unique interuniversity collaboration that brought together complementary areas of expertise. At UCLouvain (LIBST), David Alsteens is head of the NanoBiophysics lab,
- After months of technology scouting, due diligence and negotiation with all the parties involved, we're delighted to finally share this news. BXVentures is proud to be co-founder of two innovative ventures: Fluiscope - developing point-of-need diagnostic solutions. SiPulse Technologies - developing silicon sensors for the predictive maintenance of critical electrical infrastructure. Taking a technology from the lab to a company takes far more than good science. It takes partners who are willing to back a project long before it
- SOPARTEC est fière de voir aboutir la création d'Intercept Bio, une nouvelle spin-off conjointe de l'UCLouvain et l'Université de Namur. Félicitations aux chercheurs David Alsteens et Stéphane VINCENT, ainsi qu'à toutes les équipes impliquées. Au-delà de l'excellence scientifique, ce projet illustre parfaitement le rôle du transfert technologique : transformer des années de recherche fondamentale en une spin-off capable d'amener l'innovation auprès des patients. Au sein de UCLouvain - LouvainTransfer - Research & Innovation et aux
Alumni 1 went on to found or lead
Francois BlondelDirector→Executive Chairman of the Board, Founder at KiOmed Pharma
Something wrong or missing? Send an update. Fixed within 24 hours.